Getting overwhelmed by the news is an everyday struggle for those wishing to stay in touch with the latest news. Our newsletter should make it easier for those interested in pharmacovigilance regulations, advancement in the relevant use of artificial intelligence, and personal growth. Approaching with care, the same as we provide PV services, we thoughtfully pick articles every month to keep you updated.
The European Medicines Agency (EMA) supports global efforts to respond to existing and emerging public health threats. Microsoft announced Thursday that it is unveiling several artificial intelligence enhancements in Microsoft Cloud for Healthcare innovations including new healthcare AI models in Azure AI Studio. This study sought to determine if a standardized root cause analysis (RCA2) selection algorithm. And much more...
The European Medicines Agency (EMA) supports global efforts to respond to existing and emerging public health threats. These include antimicrobial resistance, biological and chemical threats and emergencies such as outbreaks or pandemics. EMA has a number of mechanisms in place to contribute to global responses to such challenges.
EMA and the European medicines regulatory network are working to further improve efficiency in the assessment and approval processes for new medicines in the European Union. The initiative aims to better manage the use of the network's expert resources, streamline assessment processes and encourage better and more comprehensive application dossiers from applicants at the time of initial submission.
International regulators have published a report highlighting their considerations on the development, clinical trials and availability of vaccines and therapeutics for mpox. The report presents the outcomes of a workshop that was organised by EMA under the umbrella of the International Coalition of Medicines Regulatory Authorities (ICMRA).
Microsoft announced Thursday that it is unveiling several artificial intelligence enhancements in Microsoft Cloud for Healthcare innovations including new healthcare AI models in Azure AI Studio, new healthcare data capabilities in Microsoft Fabric and developer tools in Copilot Studio. Many of the artificial intelligence enhancements are available by preview.
Responsible artificial intelligence is basically the only way to go if one is implementing AI technology at their hospital or health system. It is crucial that AI, as complex and important as it is, be trustworthy.
Mental health disorders pose an increasing public health challenge worsened by the COVID-19 pandemic. The pandemic highlighted gaps in preparedness, emphasizing the need for early identification of at-risk groups and targeted interventions. This study aims to develop a risk assessment tool for anxiety, depression, and self-perceived stress using machine learning (ML) and explainable AI to identify key risk factors and stratify the population into meaningful risk profiles.
This study sought to determine if a standardized root cause analysis (RCA2) selection algorithm, developed by the Veterans Affairs, would select high-risk events for RCA.
Healthcare professionals are reminded to inform patients about the common and serious side effects associated with glucagon-like peptide-1 receptor agonists (GLP-1RAs).
Introduction Patient safety (PS) is a global public health concern. It is estimated that 10% of patients experience preventable harm while hospitalized. Patient safety culture (PSC) has been recognized as essential to improving PS, drawing inspiration from other high-risk industries.
Pictures used in this newsletter were generated by AI.